Search
Login
My Portfolios Login
TradeMachine® Login
CML Research Pro Login
Get TradeMachine®
Get CML Research
Compare Products
Home
My Portfolios
CMLViz News
Breaking
Stock
Scanner
Tear Sheet
News
Profile
Stats
Stock Chart
Pivot Points
Financial Charts
Holders
Analysts
Day Trader
Back-Tester
SPX
4,158.24
+103.12
(
+2.48%
)
Dow 30
+1.74%
QQQ
+3.31%
VIX
25.72
-1.78
(
-6.47%
)
Staar Surgical Co.
NASDAQ:STAA
67.04
+4.18
(
+6.65%
)
Products
Staar Surgical Announces U.S. FDA Approval Of Evo Visian Implantable Collamer Lenses
Published: 03/28/2022 07:08 GMT
STAA
Staar Surgical Co. (
STAA
)
- Staar Surgical Announces U.S. FDA Approval of Evo Visian® Implantable Collamer® Lenses.commercialization of Evo in U.S. Will Begin Immediately.